Subcutaneous ICD noninferior to transvenous ICD
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Cardiology"
DOI: 10.1038/s41569-020-00440-0
Abstract: Many patients with homozygous familial hypercholesterolaemia (FH) do not reach guideline recommended levels of LDL cho lesterol (LDL C) with currently available therapies. A phase III trial now shows that treatment with evinacumab, a monoclonal… read more here.
Keywords: noninferior transvenous; transvenous icd; icd noninferior; placebo ... See more keywords
Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
Sign Up to like & getrecommendations! Published in 2023 at "Europace"
DOI: 10.1093/europace/euad122.427
Abstract: Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific Medical device company St. Paul, Minnesota, USA Introduction The PRAETORIAN trial showed that the subcutaneous implantable cardioverter defibrillator (S-ICD)… read more here.
Keywords: health; transvenous icd; icd; therapy ... See more keywords
Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
Sign Up to like & getrecommendations! Published in 2023 at "Europace"
DOI: 10.1093/europace/euad122.434
Abstract: Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Small fee from Boston Scientific. Background The use of subcutaneous defibrillator (S-ICD) is a viable alternative to transvenous ICD in patients with Arrhythmogenic… read more here.
Keywords: time; year; transvenous icd; icd ... See more keywords